Strattera and Vivelle drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Strattera (atomoxetine hydrochloride) and Vivelle (estradiol). Common drug interactions include nausea among females.

The phase IV clinical study analyzes what interactions people have when they take Strattera and Vivelle. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,324 Strattera users. Check the latest studies of Strattera.

What is Vivelle?

Vivelle has active ingredients of estradiol. It is often used in hormone replacement therapy. eHealthMe is studying from 6,624 Vivelle users. Check the latest studies of Vivelle.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

14 people who take Strattera and Vivelle together, and have interactions are studied.

Strattera and Vivelle drug interactions.

What are the common drug interactions of Strattera and Vivelle, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Fatigue (feeling of tiredness)
Drug ineffective
Asthenia (weakness)
Chest discomfort
Dyspnoea (difficult or laboured respiration)
Pallor
Syncope (loss of consciousness with an inability to maintain postural tone)
Vomiting
Chest pain

male:

n/a

What are the common drug interactions of Strattera and Vivelle, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Dry mouth
Fatigue (feeling of tiredness)
Irritability
Mood swings (an extreme or rapid change in mood)
Sluggishness (lacking alertness)

50-59:

Pancreatic carcinoma stage ii (pancreatic cancer stage ii)

60+:

Nausea (feeling of having an urge to vomit)
Gastric ulcer (stomach ulcer)
Fatigue (feeling of tiredness)
Headache (pain in head)
Migraine (headache)
Pallor
Vomiting
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Abdominal pain upper
Acute myocardial infarction (acute heart attack)

What are the existing conditions these people have? *

Pain: 4 people, 28.57%
Osteoporosis (bones weak and more likely to break): 4 people, 28.57%
Intervertebral Disc Operation: 2 people, 14.29%
Type 2 Diabetes: 1 person, 7.14%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 7.14%
Intervertebral Disc Protrusion (spinal disc protrusion): 1 person, 7.14%
Back Pain: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and Vivelle?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously